NDRI has made a commitment to the collection of cord blood and adult bone marrow. Umbilical cord blood is a plentiful and rich source of stem cells that is currently being studied to treat a variety of diseases. Bone marrow from vertebral bodies is processed from cadaver donors and shipped fresh or cryopreserved. Scientists procure these resources to understand the mechanisms of stem cell growth and proliferation, developing therapies that may one day be used to treat a host of common diseases.
- Cord Blood
- Donor consent assured
- Received within 24 hours of birth
- Donor anonymity maintained
- Basic donor statistics available
- Cord Blood Products
- CD34+ cells in aliquots of 5x10^5
- CD34+ cells in aliquots of 1x10^6
- CD31+/45- endothelial progenitor cells in aliquots of 1x10^6
- Patented cell processing technology
- Single donor specimens, no pooling
- Specimens come with a CoA and a
- User's Guide of Instructions
- Adult Vertebral Bodies
- Bone Marrow Derivatives
- Bone marrow available fresh or cryopreserved
- Delivery within 24 hours of processing
- CD34+ cells in aliquots of 1x10^6
- CD34+ cells in aliquots of 5x10^6
- CD34+ depleted MNC cells in aliquots of 2.5x10^8
- Vertebral body bone chips available
- Full serology panel
- Quality assurance data supplied
- Specimens come with a CoA and a User's Guide of Instructions
- Cord blood and cord blood products supplied by NDRI are being utilized for research in the following areas:
- Finding more effective methods to counteract immune depression in cancer patients;
- The development of new strategies to treat Kawasaki Disease;
- Improving methods of suppression for human cytomegalovirus;
- Stem cell gene therapy;
- Prevention and control of E. Coli bacterial infection;
- The identification of novel tumor antigens;
- Angiogenesis research;
- Anti-angiogenesis validations;
- Vasculogenesis research;
- Arthrogenesis research;
- Regenerative studies, and;
- Organ repair
- Adult bone marrow is recovered for a variety of research initiatives, including:
- The examination of the biochemical and molecular events regulating lineage-specific progenitor cell differentiation;
- Gene therapy and the development of targeted monoclonal antibodies;
- The development of photochemical treatment against Parvovirus;
- Cellular replacement therapy for neurological diseases such as Alzheimer's, Parkinson's Disease, ALS (Lou Gehrig's Disease) and spinal cord injuries, and;
- Cellular replacement therapy for cancer and diabetes.
Download a FAQ about obtaining CD 34+ cells and bone marrow.
Download a FAQ about obtaining CD 31+/45 endothelial colony forming cells.
Download a research application form.